Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Tysabri (natalizumab)
i
Other names:
AN100226, AN 100226, BG00002, BG-0002, AN-10022, BG-00002, BG-0002-E
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Biogen, Royalty
Drug class:
α4β1 integrin antagonist, α4β7 integrin antagonist
Related drugs:
‹
vedolizumab (0)
vedolizumab (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.